IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGATES FOR TREATING CANCER Application WO-2023017191-A1 World Intellectual Property Organisation (WIPO) 16 Feb 2023
COMBINATION-THERAPY ANTIBODY DRUG CONJUGATE WITH IMMUNE CELL INHIBITOR Application WO-2022098972-A1 World Intellectual Property Organisation (WIPO) 12 May 2022